Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1976 1
1977 1
1978 4
1979 1
1980 3
1981 8
1982 6
1983 2
1984 2
1985 1
1987 1
1988 2
1989 2
1990 10
1991 4
1992 7
1993 11
1994 6
1995 8
1996 10
1997 6
1998 2
2000 1
2001 2
2002 1
2003 4
2004 4
2005 3
2006 5
2007 10
2008 4
2009 10
2010 2
2011 1
2012 8
2013 6
2014 9
2015 3
2016 3
2017 2
2019 3
2020 1
2021 5
2022 0
Text availability
Article attribute
Article type
Publication date

Search Results

174 results
Results by year
Filters applied: . Clear all
Page 1
Specific Susceptibility to COVID-19 in Adults with Down Syndrome.
Illouz T, Biragyn A, Frenkel-Morgenstern M, Weissberg O, Gorohovski A, Merzon E, Green I, Iulita F, Flores-Aguilar L, Dierssen M, De Toma I, Lifshitz H, Antonarakis SE, Yu E, Herault Y, Potier MC, Botté A, Roper R, Sredni B, Sarid R, London J, Mobley W, Strydom A, Okun E. Illouz T, et al. Among authors: sredni b. Neuromolecular Med. 2021 Dec;23(4):561-571. doi: 10.1007/s12017-021-08651-5. Epub 2021 Mar 4. Neuromolecular Med. 2021. PMID: 33660221 Free PMC article.
Cancer immunotherapy: are we there yet?
Sredni B, Longo DL. Sredni B, et al. Semin Cancer Biol. 2012 Feb;22(1):1-2. doi: 10.1016/j.semcancer.2012.01.001. Epub 2012 Jan 8. Semin Cancer Biol. 2012. PMID: 22240249 No abstract available.
Correction to: Specific Susceptibility to COVID-19 in Adults with Down Syndrome.
Illouz T, Biragyn A, Frenkel-Morgenstern M, Weissberg O, Gorohovski A, Merzon E, Green I, Iulita F, Flores-Aguilar L, Dierssen M, De Toma I, Lifshitz H, Antonarakis SE, Yu E, Herault Y, Potier MC, Botté A, Roper R, Sredni B, Sarid R, London J, Mobley W, Strydom A, Okun E. Illouz T, et al. Among authors: sredni b. Neuromolecular Med. 2021 Dec;23(4):572-573. doi: 10.1007/s12017-021-08657-z. Neuromolecular Med. 2021. PMID: 33948879 Free PMC article. No abstract available.
Correction to: Specific Susceptibility to COVID-19 in Adults with Down Syndrome.
Illouz T, Biragyn A, Frenkel-Morgenstern M, Weissberg O, Gorohovski A, Merzon E, Green I, Iulita F, Flores-Aguilar L, Dierssen M, De Toma I, Lifshitz H, Antonarakis SE, Yu E, Herault Y, Potier MC, Botté A, Roper R, Sredni B, Sarid R, London J, Mobley W, Strydom A, Okun E. Illouz T, et al. Among authors: sredni b. Neuromolecular Med. 2021 Dec;23(4):574-575. doi: 10.1007/s12017-021-08695-7. Neuromolecular Med. 2021. PMID: 34797469 Free PMC article. No abstract available.
Immune Dysregulation and the Increased Risk of Complications and Mortality Following Respiratory Tract Infections in Adults With Down Syndrome.
Illouz T, Biragyn A, Iulita MF, Flores-Aguilar L, Dierssen M, De Toma I, Antonarakis SE, Yu E, Herault Y, Potier MC, Botté A, Roper R, Sredni B, London J, Mobley W, Strydom A, Okun E. Illouz T, et al. Among authors: sredni b. Front Immunol. 2021 Jun 25;12:621440. doi: 10.3389/fimmu.2021.621440. eCollection 2021. Front Immunol. 2021. PMID: 34248930 Free PMC article. Review.
174 results